NCT04481620View on ClinicalTrials.gov

Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT

CompletedOBSERVATIONAL
Enrollment

1,329

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

May 4, 2021

Study Completion Date

May 4, 2021

Conditions
COVID-19
Trial Locations (7)

Unknown

CHU Bordeaux, Bordeaux

Clinique Bordeaux Nord, Bordeaux

Clinique Saint Augustin, Bordeaux

CHU de Grenoble Alpes, Grenoble

Hôpital Arnaud-de-Villeneuve CHU de Montpellier, Montpellier

Hôpitaux de Brabois CHU de Nancy, Nancy

Hôpital de la Milétrie CHU de Poitiers, Poitiers

All Listed Sponsors
collaborator

Programme Hospitalier de Recherche Clinique Inter-Régionale (PHRC-I)

UNKNOWN

lead

University Hospital, Bordeaux

OTHER

NCT04481620 - Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT | Biotech Hunter | Biotech Hunter